MitraClip Readies For Mitral Regurgitation Study
October 27th, 2008If you follow the latest technology and medical advancements of heart valve surgery, I thought you would enjoy this update and video:
Evalve, Inc., a leading provider of minimally invasive mitral valve repair techniques, has completed randomized enrollment in the endovascular valve edge-to-edge repair study, which is evaluating the MitraClip system as a non-surgical repair option for patients suffering from mitral regurgitation. This study is an FDA-approved Phase II randomized, controlled, multi-center clinical research study in the US and Canada evaluating the safety and efficacy of the MitraClip device in 279 patients with moderate-to-severe mitral regurgitation.
Donald Glower, professor of surgery at Duke Medical Center and co-principal investigator of the Everest study, said: “This trial sets a high scientific standard for future mitral percutaneous valve therapies. As a result, this trial will have a significant and long-lasting impact on patient care around the world.”
Keep on tickin!

![]() |
| About The Author: Adam Pick is a double, heart valve surgery patient and author of The Patient's Guide To Heart Valve Surgery. This unique book integrates clinical research with the personal experiences of 135 former patients to help future patients and their caregivers better understand the problems, the opportunities and the realities of heart valve surgery. To learn more about Adam and his heart valve surgery book, click here. |
![]() |




















